Is Thanatophoric Dysplasia hereditary?

Thanatophoric Dysplasia is a genetic condition caused by spontaneous mutations, but it is not typically considered "hereditary" in the sense of being passed down from parents. Because the condition is almost always the result of a de novo (new) mutation in the FGFR3 gene, the recurrence risk for unaffected parents having another child with Thanatophoric Dysplasia is generally less than 1%.

Is Thanatophoric Dysplasia considered hereditary?

While Thanatophoric Dysplasia is a genetic disorder, it is rarely inherited. In nearly all documented cases, the condition arises from a de novo mutation in the FGFR3 gene that occurs spontaneously in the egg or sperm cell at the time of conception. Because the mutation is not present in the parents' own genetic makeup, it is not "hereditary" in the traditional familial sense.

What is the inheritance pattern and recurrence risk?

Thanatophoric Dysplasia follows an autosomal dominant pattern of inheritance, meaning only one copy of the altered gene is sufficient to cause the condition. However, because the mutation occurs spontaneously, the vast majority of cases are isolated within a family. For parents who have had a child with Thanatophoric Dysplasia, the likelihood of having another child with the same condition is extremely low, generally estimated at less than 1% due to the rare possibility of germline mosaicism in a parent.

How is genetic testing and diagnosis managed?

Genetic testing for Thanatophoric Dysplasia is highly effective and is typically performed through molecular analysis of the FGFR3 gene. Clinical management and confirmation usually involve:

• Prenatal Ultrasound: Often the first indicator, showing characteristic skeletal features like a narrow thorax and bowed femurs.


• Molecular Genetic Testing: Confirms the presence of specific pathogenic variants in the FGFR3 gene.


• Genetic Counseling: Essential for families to understand the nature of de novo mutations and to discuss reproductive options for future pregnancies.

Next steps

• Consult with a board-certified clinical geneticist to discuss testing results and recurrence risks.


• Connect with the 36 members of the Thanatophoric Dysplasia community on DiseaseMaps.org for peer support.


• Request a referral to a high-risk maternal-fetal medicine specialist if you are planning a future pregnancy.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Thanatophoric Dysplasia


• Orphanet: Thanatophoric Dysplasia (ORPHA:267)


• OMIM (Online Mendelian Inheritance in Man): Thanatophoric Dysplasia, Type I (#187600)


• National Organization for Rare Disorders (NORD): Thanatophoric Dysplasia